ARTICLE
27 September 2016

FDA To Host Public Conference On Key Aspects Of Drug And Device Regulations

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The meeting will be available via webcast, but there will not be a transcript available following the meeting.
United States Food, Drugs, Healthcare, Life Sciences

In the August 30, 2016, Federal Register, FDA announced it will sponsor a two-day conference titled "FDA Small Business and Industry Assistance Regulatory Education for Industry Fall Conference." The conference is designed for small manufacturers of drugs and/or medical devices who want to learn about FDA's approach to regulating drugs and devices, but anyone involved in the pharmaceutical and/or device industry may attend. Center for Drug Evaluation and Research topics for discussion include manufacturing process validation, interactions with FDA, emerging technology and inspection for new drug applications, and biologic license applications. CDRH topics for discussion include de novo, design controls, and complaints. The meeting will be available via webcast, but there will not be a transcript available following the meeting. The public conference will be held September 27 and 28, 2016.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More